Literature DB >> 7553001

Reconstitution of invariant chain function in transgenic mice in vivo by individual p31 and p41 isoforms.

I Shachar1, E A Elliott, B Chasnoff, I S Grewal, R A Flavell.   

Abstract

MHC class II molecules associate with invariant chain (li) during biosynthesis. If facilitates folding of class II molecules, interferes with their association with peptides, and is involved in their transport. The murine Ii gene encodes two chains, p31 and p41. The role of these isoforms has been studied in vitro only in inappropriate antigen-presenting cells. To circumvent this problem, we have generated invariant chain-deficient mice (delta Ii), which express exclusively the p31 and p41 isoforms. Low level expression of p31 or p41 is not sufficient for rescuing high levels of cell surface class II expression. However, low levels of the typical compact dimer conformation indicative of tight peptide binding are observed. Thus, both isoforms participate in class II folding and assembly. Furthermore, p31 and p41 retrieve the CD4+ T cell population, which is reduced in the (delta Ii) mice. Moreover, the immune response to protein antigen is restored by both isoforms.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7553001     DOI: 10.1016/1074-7613(95)90121-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  15 in total

1.  Invariant chain induces B cell maturation in a process that is independent of its chaperonic activity.

Authors:  Didi Matza; Frida Lantner; Yoel Bogoch; Liat Flaishon; Rami Hershkoviz; Idit Shachar
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-26       Impact factor: 11.205

2.  Homeostatic expansion and phenotypic conversion of naïve T cells in response to self peptide/MHC ligands.

Authors:  W C Kieper; S C Jameson
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

Review 3.  Thymic stromal cell specialization and the T-cell receptor repertoire.

Authors:  D Lo; C R Reilly; L C Burkly; J DeKoning; T M Laufer; L H Glimcher
Journal:  Immunol Res       Date:  1997-02       Impact factor: 2.829

4.  Shark class II invariant chain reveals ancient conserved relationships with cathepsins and MHC class II.

Authors:  Michael F Criscitiello; Yuko Ohta; Matthew D Graham; Jeannine O Eubanks; Patricia L Chen; Martin F Flajnik
Journal:  Dev Comp Immunol       Date:  2011-10-01       Impact factor: 3.636

5.  Molecular cloning and expression of two chicken invariant chain isoforms produced by alternative splicing.

Authors:  Dalian Zhong; Weiyi Yu; Yuhua Liu; Jing Liu; Jinnian Li
Journal:  Immunogenetics       Date:  2004-11-16       Impact factor: 2.846

6.  Requirement for endocytic antigen processing and influence of invariant chain and H-2M deficiencies in CNS autoimmunity.

Authors:  A J Slavin; J M Soos; O Stuve; J C Patarroyo; H L Weiner; A Fontana; E K Bikoff; S S Zamvil
Journal:  J Clin Invest       Date:  2001-10       Impact factor: 14.808

7.  CD74 is a member of the regulated intramembrane proteolysis-processed protein family.

Authors:  Shirly Becker-Herman; Galit Arie; Helena Medvedovsky; Anat Kerem; Idit Shachar
Journal:  Mol Biol Cell       Date:  2005-08-17       Impact factor: 4.138

8.  The Ii41 isoform of invariant chain mediates both positive and negative selection events in T-cell receptor transgenic mice.

Authors:  R J Wright; E K Bikoff; B Stockinger
Journal:  Immunology       Date:  1998-11       Impact factor: 7.397

9.  A retroviral mutagenesis screen identifies Cd74 as a common insertion site in murine B-lymphomas and reveals the existence of a novel IFNgamma-inducible Cd74 isoform.

Authors:  Magdalena Pyrz; Bruce Wang; Matthias Wabl; Finn Skou Pedersen
Journal:  Mol Cancer       Date:  2010-04-23       Impact factor: 27.401

10.  Mad3 negatively regulates B cell differentiation in the spleen by inducing Id2 expression.

Authors:  Yael Gore; Frida Lantner; Gili Hart; Idit Shachar
Journal:  Mol Biol Cell       Date:  2010-04-07       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.